Titan Pharmaceuticals (TTNP) just unveiled an update.
Titan Pharmaceuticals, Inc. (TTNP) has entered into a significant Merger Agreement that will reshape its corporate structure and ownership. Under the agreement, TTNP and KE Sdn. Bhd. will be acquired by BSKE Ltd., with TTNP becoming a wholly owned subsidiary and KE Sdn. Bhd. potentially becoming a direct wholly owned subsidiary if all conditions are met. This complex transaction includes share exchanges, mergers, and various conditions including financing and regulatory approvals. Stockholders of TTNP and KE Sdn. Bhd. are poised to receive newly issued shares in BSKE Ltd., and TTNP aims to secure a Nasdaq listing for the BSKE Ordinary Shares post-merger. The transaction is set to significantly alter the ownership percentages within the newly combined entity, with detailed terms and conditions outlined in the Merger Agreement.
See more data about TTNP stock on TipRanks’ Stock Analysis page.
